IBDEI0TX ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13464,1,3,0)
 ;;=3^Convergence Excess
 ;;^UTILITY(U,$J,358.3,13464,1,4,0)
 ;;=4^H51.12
 ;;^UTILITY(U,$J,358.3,13464,2)
 ;;=^5006252
 ;;^UTILITY(U,$J,358.3,13465,0)
 ;;=H51.11^^51^637^18
 ;;^UTILITY(U,$J,358.3,13465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13465,1,3,0)
 ;;=3^Convergence Insufficiency
 ;;^UTILITY(U,$J,358.3,13465,1,4,0)
 ;;=4^H51.11
 ;;^UTILITY(U,$J,358.3,13465,2)
 ;;=^5006251
 ;;^UTILITY(U,$J,358.3,13466,0)
 ;;=H47.612^^51^637^19
 ;;^UTILITY(U,$J,358.3,13466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13466,1,3,0)
 ;;=3^Cortical Blindness,Left Side of Brain
 ;;^UTILITY(U,$J,358.3,13466,1,4,0)
 ;;=4^H47.612
 ;;^UTILITY(U,$J,358.3,13466,2)
 ;;=^5006167
 ;;^UTILITY(U,$J,358.3,13467,0)
 ;;=H47.611^^51^637^20
 ;;^UTILITY(U,$J,358.3,13467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13467,1,3,0)
 ;;=3^Cortical Blindness,Right Side of Brain
 ;;^UTILITY(U,$J,358.3,13467,1,4,0)
 ;;=4^H47.611
 ;;^UTILITY(U,$J,358.3,13467,2)
 ;;=^5006166
 ;;^UTILITY(U,$J,358.3,13468,0)
 ;;=H53.2^^51^637^21
 ;;^UTILITY(U,$J,358.3,13468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13468,1,3,0)
 ;;=3^Diplopia
 ;;^UTILITY(U,$J,358.3,13468,1,4,0)
 ;;=4^H53.2
 ;;^UTILITY(U,$J,358.3,13468,2)
 ;;=^35208
 ;;^UTILITY(U,$J,358.3,13469,0)
 ;;=H47.642^^51^637^22
 ;;^UTILITY(U,$J,358.3,13469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13469,1,3,0)
 ;;=3^Disord of Visual Cortex in Vasc Disord,Left Side of Brain
 ;;^UTILITY(U,$J,358.3,13469,1,4,0)
 ;;=4^H47.642
 ;;^UTILITY(U,$J,358.3,13469,2)
 ;;=^5006176
 ;;^UTILITY(U,$J,358.3,13470,0)
 ;;=H47.641^^51^637^23
 ;;^UTILITY(U,$J,358.3,13470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13470,1,3,0)
 ;;=3^Disord of Visual Cortex in Vasc Disord,Right Side of Brain
 ;;^UTILITY(U,$J,358.3,13470,1,4,0)
 ;;=4^H47.641
 ;;^UTILITY(U,$J,358.3,13470,2)
 ;;=^5006175
 ;;^UTILITY(U,$J,358.3,13471,0)
 ;;=H50.51^^51^637^24
 ;;^UTILITY(U,$J,358.3,13471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13471,1,3,0)
 ;;=3^EP Esophoria
 ;;^UTILITY(U,$J,358.3,13471,1,4,0)
 ;;=4^H50.51
 ;;^UTILITY(U,$J,358.3,13471,2)
 ;;=^265435
 ;;^UTILITY(U,$J,358.3,13472,0)
 ;;=H50.00^^51^637^25
 ;;^UTILITY(U,$J,358.3,13472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13472,1,3,0)
 ;;=3^ET Esotropia,Unspec
 ;;^UTILITY(U,$J,358.3,13472,1,4,0)
 ;;=4^H50.00
 ;;^UTILITY(U,$J,358.3,13472,2)
 ;;=^5006208
 ;;^UTILITY(U,$J,358.3,13473,0)
 ;;=G51.4^^51^637^26
 ;;^UTILITY(U,$J,358.3,13473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13473,1,3,0)
 ;;=3^Facial Myokymia
 ;;^UTILITY(U,$J,358.3,13473,1,4,0)
 ;;=4^G51.4
 ;;^UTILITY(U,$J,358.3,13473,2)
 ;;=^5003996
 ;;^UTILITY(U,$J,358.3,13474,0)
 ;;=M31.6^^51^637^27
 ;;^UTILITY(U,$J,358.3,13474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13474,1,3,0)
 ;;=3^Giant Cell Arteritis NEC
 ;;^UTILITY(U,$J,358.3,13474,1,4,0)
 ;;=4^M31.6
 ;;^UTILITY(U,$J,358.3,13474,2)
 ;;=^5011748
 ;;^UTILITY(U,$J,358.3,13475,0)
 ;;=H53.47^^51^637^29
 ;;^UTILITY(U,$J,358.3,13475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13475,1,3,0)
 ;;=3^Heteronymous Bilateral Field Defects
 ;;^UTILITY(U,$J,358.3,13475,1,4,0)
 ;;=4^H53.47
 ;;^UTILITY(U,$J,358.3,13475,2)
 ;;=^268847
 ;;^UTILITY(U,$J,358.3,13476,0)
 ;;=H50.50^^51^637^30
 ;;^UTILITY(U,$J,358.3,13476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13476,1,3,0)
 ;;=3^Heterophoria
